Reduced virulence of Candida albicans MKC1 mutants: a role for mitogen-activated protein kinase in pathogenesis

R Diez-Orejas1, G Molero, F Navarro-García

  • 1Departamento de Microbiología II, Facultad de Farmacia, Universidad Complutense, Madrid, Spain.

Infection and Immunity
|February 1, 1997
PubMed

Insights

Deleting the Candida albicans MKC1 gene, crucial for cell integrity, reduced fungal pathogenicity in mice. This study highlights the cell integrity pathway

Area of Science:

  • Microbiology
  • Mycology
  • Molecular Biology

Background:

  • The Candida albicans MKC1 gene encodes a mitogen-activated protein kinase essential for cell integrity.
  • Previous research established the role of MKC1 in maintaining cell wall integrity in Candida albicans.

Purpose of the Study:

  • To investigate the role of the cell integrity pathway, specifically the MKC1 gene, in the pathogenicity of Candida albicans.
  • To determine if disruption of the MKC1 gene affects the virulence of Candida albicans in a murine infection model.

Main Methods:

  • Gene deletion to create a mkc1 delta/mkc1 delta mutant strain of Candida albicans.
  • Experimental infection of a murine model using both the wild-type and mutant strains.
  • Assessment of pathogenicity through survival time, mortality rates, fungal load in organs, and histological analysis.

Main Results:

  • Deletion of the MKC1 gene resulted in viable Candida albicans cells with compromised cell integrity.
  • The mkc1 delta/mkc1 delta strain exhibited significantly reduced pathogenicity compared to the parental strain in the murine model.
  • Key indicators of reduced pathogenicity included prolonged survival times, lower mortality percentages, decreased fungal loads in organs, and altered histological findings.

Conclusions:

  • The cell integrity pathway, mediated by the MKC1 gene, plays a critical role in the pathogenicity of Candida albicans.
  • This is the first study to demonstrate the involvement of the cell integrity pathway in the virulence of a dimorphic fungus.
  • Targeting the cell integrity pathway could be a potential strategy for developing novel antifungal therapies against Candida albicans infections.